BRIEF-Element Biosciences Says Upsized Series E Round Of Financing Includes $175 Mln From Samsung Electronics

June 9 (Reuters) - Element Biosciences:

  • ELEMENT BIOSCIENCES ANNOUNCES UPSIZED SERIES E TO ACCELERATE GLOBAL GROWTH ACROSS ECOSYSTEM OF GENOMIC, MULTIOMIC, AND CLINICAL RESEARCH SOLUTIONS

  • ELEMENT BIOSCIENCES: UPSIZED SERIES E ROUND OF FINANCING, INCLUDING $175 MILLION FROM LONGSTANDING INVESTOR SAMSUNG ELECTRONICS

  • ELEMENT BIOSCIENCES: NEW CAPITAL WILL SUPPORT COMMERCIALIZATION ADOPTION OF ELEMENT'S PORTFOLIO OF GENOMIC MULTIOMIC TECHNOLOGIES INCLUDING AVITI

Source text: ID:nBw947z7ma


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.